Market Overview:
Central Venous Catheters Market size was valued US$ 1,994.72 million in 2021 and is estimated to reach US$ 3,760.83 million by 2029, growing at a CAGR of 5.9% during the forecast period (2022-2029).
Central venous catheters also known as relevant traces are commonly used to get entry to the venous system. These catheters are skinny, bendy tubes which are located into the huge vein above the coronary heart. These are inserted thru the internal jugular vein, femoral vein, and subclavian vein and assist inside the transport of intravenous fluids, blood merchandise, medicines, parenteral nutrients, and series of blood samples. It also monitors hemodynamic variables, measures vital venous strain, hemodialysis and chemotherapy.
Central venous catheters want special care like regular cleaning or dressing employing sterile techniques. More than 5 million valuable venous catheters are inserted within the U.S. Every yr. Central venous catheters are used whilst conventional methods of providing medicinal drug are not responding.
To Download free sample @ Click Here
Market Dynamics
The increasing prevalence of chronic diseases and growing technological improvements are predicted to pressure the boom of the market.
The main drivers fueling the growth of the marketplace are the excessive occurrence of most cancers and chronic diseases, in particular in geriatric patients, technical improvements, and the rise in the adoption of antimicrobial catheters on a huge scale.
According to National Centre for Health, in 2022, most cancers turned into the second main motive of mortality internationally, with around 1,918,030 new instances registered in 2022. Cancer turned into accountable for 609,360 deaths everywhere in the international.
Moreover, as in step with WHO the wide variety of latest instances is predicted to upward thrust with the aid of around 70% with the aid of 2030. The management of chemotherapy pills is more green with the assist of relevant venous catheters, and there is an upward push in the adoption of antimicrobial catheters among cancer sufferers globally.
Even continual sicknesses consisting of renal illnesses require catheters, in step with the have a look at by way of the University of California, around five million human beings international are tormented by end-stage renal ailment (ESRD), and the quantity of sufferers identified with the disease is anticipated to grow at a charge of five-7% yearly.
Various novel technological advances and today’s product launch with modern-day technology will make contributions closer to the increase of significant venous catheters. For instance, In Jan 2021, Medtronic introduced that the DiamondTemp ablation machine got authorized with the aid of the United States Food and Drug Administration for the remedy of sufferers that have recurrent, paroxysmal atrial traumatic inflammation.
Market Segmentation:
By Property Type
- Antimicrobial Coated
- Non-antimicrobial coated
By Product Type
- Tunneled
- Non-tunneled
By Design Type
- single- Lumen
- Double-Lumen
- Triple-Lumen
- Multi-Lumen
By Material Composition Type
- Soft
- Rigid
By Application
- Jugular Vein Cannulation
- Subclavian Vein Cannulation
- Femoral Vein Cannulation
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty clinics
Competitive Landscape
Some of the major key players in the global central venous catheters market are AngioDynamics, B.Braun, Becton Dickinson Company, C.R. Bard, Edwards Lifesciences, Medtronic Plc, Teleflex, Terumo Corporation, and Smiths medical.
The global CVC market is a consolidated market with three companies occupying the majority of the market share. Globally, over 70% of the CVC market is attributed to three major players which are headquartered in the US or Europe. These recognized players include Teleflex, C.R Bard, and B Braun.
Companies are focusing on key strategies such as collaboration, acquisitions, and product launches which are boosting the growth of the market globally. For instance,
In Jul 2022, B. Braun Medical Inc. developer of infusion therapy launched its one-time blood control Introcan safety 2 IV catheter. It is developed for safe IV access.
In Apr 2022, Terumo announced that Thoraflex hybrid frozen elephant trunk device gor approved by United Stated Food and Drug Administration for commercialising it in U.S. for complex aortic arch disease treatment.
Trending Topics:
Aneurysm Coiling and Embolization Devices Market
Autotransfusion Devices and Consumables Market
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/central-venous-catheters-market